Literature DB >> 16195419

Molecular mechanisms for large conductance Ca2+-activated K+ channel activation by a novel opener, 12,14-dichlorodehydroabietic acid.

Kazuho Sakamoto1, Taro Nonomura, Susumu Ohya, Katsuhiko Muraki, Tomohiko Ohwada, Yuji Imaizumi.   

Abstract

Our recent study has revealed that 12,14-dichlorodehydroabietic acid (diCl-DHAA), which is synthetically derived from a natural product, abietic acid, is a potent opener of large conductance Ca(2+)-activated K(+) (BK) channel. Here, we examined, by using a channel expression system in human embryonic kidney 293 cells, the mechanisms underlying the BK channel opening action of diCl-DHAA and which subunit of the BK channel (alpha or beta1) is the site of action for diCl-DHAA. BK channel activity was significantly enhanced by diCl-DHAA at concentrations of 0.1 microM and higher in a concentration-dependent manner. diCl-DHAA enhanced the activity of BKalpha by increasing sensitivity to both Ca(2+) and membrane potential without changing the single channel conductance. It is notable that the increase in BK channel open probability by diCl-DHAA showed significant inverse voltage dependence, i.e., larger potentiation at lower potentials. Since coexpression of beta1 subunit with BKalpha did not affect the potency of diCl-DHAA, the site of action for diCl-DHAA is suggested to be BKalpha subunit. Moreover, kinetic analysis of single channel currents indicates that diCl-DHAA opens BKalpha mainly by decreasing the time staying in a long closed state. Although reconstituted voltage-dependent Ca(2+) channel current was significantly reduced by 1 microM diCl-DHAA, BK channels were selectively activated at lower concentrations. These results indicate that diCl-DHAA is one of the most potent BK channel openers acting on BKalpha and a useful prototype compound to develop a novel BK channel opener.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195419     DOI: 10.1124/jpet.105.093856

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  BK channel activation by NS11021 decreases excitability and contractility of urinary bladder smooth muscle.

Authors:  Jeffrey J Layne; Bernhard Nausch; Søren-Peter Olesen; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

2.  Modulation of Ca2+ oscillation and melatonin secretion by BKCa channel activity in rat pinealocytes.

Authors:  Hiroya Mizutani; Hisao Yamamura; Makoto Muramatsu; Yumiko Hagihara; Yoshiaki Suzuki; Yuji Imaizumi
Journal:  Am J Physiol Cell Physiol       Date:  2016-01-20       Impact factor: 4.249

3.  Inhibition of martentoxin on neuronal BK channel subtype (alpha+beta4): implications for a novel interaction model.

Authors:  Jian Shi; Hui Qiong He; Rong Zhao; Yan-Hong Duan; Jin Chen; Ying Chen; Juan Yang; Jian Wei Zhang; Xue Qin Shu; Ping Zheng; Yong Hua Ji
Journal:  Biophys J       Date:  2008-01-16       Impact factor: 4.033

4.  Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo.

Authors:  Bo Hjorth Bentzen; Rune Wederkinck Andersen; Søren-Peter Olesen; Morten Grunnet; Antonio Nardi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-10-02       Impact factor: 3.000

Review 5.  Alternative Targets for Modulators of Mitochondrial Potassium Channels.

Authors:  Antoni Wrzosek; Shur Gałecka; Monika Żochowska; Anna Olszewska; Bogusz Kulawiak
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

Review 6.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

7.  Synthesis, antitumor and DNA cleavage activities of a novel class of dehydroabietylamine derivatives.

Authors:  Jincai Li; Chaoxiang Liu
Journal:  Heliyon       Date:  2020-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.